Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstanbul University - Cerrahpasa

About this trial

This prospective single-center observational study aims to evaluate whether the ultrasound-measured femoral vein-to-femoral artery diameter ratio can predict fluid responsiveness in mechanically ventilated adult intensive care patients with acute circulatory failure or shock. Only patients who already have PiCCO monitoring as part of routine clinical care and for whom a fluid challenge is clinically indicated will be included. No additional invasive procedure will be performed for study purposes. Cardiac index will be measured with PiCCO before and after administration of 500 mL balanced crystalloid over 10 minutes, and femoral vein and femoral artery diameters will be measured by bedside ultrasonography. Fluid responsiveness will be defined as an increase of more than 10% in cardiac index after fluid administration. The study will assess the diagnostic performance of the femoral vein-to-femoral artery diameter ratio as a practical bedside parameter to support hemodynamic decision-making in critically ill patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients aged 18 years or older

Admission to the intensive care unit where the study is being conducted

Receiving invasive mechanical ventilation

Clinical indication for a fluid challenge due to acute circulatory failure or shock, as determined by the responsible intensive care physician

Disqualifiers

Age younger than 18 years

Failure to obtain written informed consent from the patient or legally authorized representative before enrollment

Absence of PiCCO monitoring as part of routine clinical care or no clinical plan for fluid challenge

Inability to complete pre- and post-fluid challenge measurements (e.g., early death, urgent surgery, transfer)

Trial population

The study population consists of adult intensive care unit patients with acute circulatory failure or shock who are receiving invasive mechanical ventilation and for whom the responsible intensive care physician has determined a clinical indication for a fluid challenge. Only patients who already have PiCCO monitoring in place as part of routine clinical care and in whom femoral vein and femoral artery ultrasonographic measurements can be obtained will be enrolled.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Ultrasound Measurement of Femoral Vein-to-Femoral Artery Diameter Ratio

    Diagnostic test

    Bedside ultrasonographic measurement of femoral vein and femoral artery diameters at the same anatomical level proximal to the femoral artery bifurcation, with at least three repeated measurements and calculation of the femoral vein-to-femoral artery diameter ratio before and after a clinically indicated fluid challenge.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Diagnostic performance of the baseline femoral vein-to-femoral artery diameter ratio for predicting fluid responsiveness

Diagnostic performance of the baseline ultrasound-measured femoral vein-to-femoral artery diameter ratio in identifying fluid responders, assessed by receiver operating characteristic analysis (area under the curve). Fluid responsiveness will be defined as an increase of more than 10% in cardiac index after administration of 500 mL balanced crystalloid over 10 minutes.

Time frame
Baseline assessment before fluid challenge, with responder status determined 10 minutes after completion of the fluid challenge

Secondary outcomes

1

Percent change in cardiac index after fluid challenge

Percent change in PiCCO-derived cardiac index after administration of 500 mL balanced crystalloid over 10 minutes.

Time frame
Before fluid challenge and 10 minutes after completion of the fluid challenge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.